Vanguard Group Inc Bluebird Bio, Inc. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 10,301,300 shares of BLUE stock, worth $5.05 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,301,300
Previous 10,498,460
1.88%
Holding current value
$5.05 Million
Previous $13.4 Million
24.88%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding BLUE
# of Institutions
160Shares Held
80MCall Options Held
525KPut Options Held
634K-
Black Rock Inc. New York, NY15.4MShares$7.57 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN6.39MShares$3.13 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.15MShares$2.52 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$2.29 Million0.02% of portfolio
-
Palo Alto Investors LP Palo Alto, CA4.63MShares$2.27 Million0.57% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $37.8M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...